Sutimlimab ( known as ) this experimental agent is the targeted protein with a identification designation of that specific identifier. The drug works by specifically inhibiting complement component 5 , https://bookmarks-hit.com/story25682131/sutimlimab-a-detailed-investigation-into-the-compound-biologic